Design Therapeutics, Inc. (DSGN)
15.55
+1.33
(+9.35%)
USD |
NASDAQ |
May 11, 16:00
15.55
0.00 (0.00%)
After-Hours: 18:52
Design Therapeutics Total Assets (Quarterly) : 230.44M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| vTv Therapeutics, Inc. | 89.90M |
| Immuneering Corp. | 231.98M |
| X4 Pharmaceuticals, Inc. | 270.28M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.39M |
| Shareholders Equity (Quarterly) | 218.05M |
| Debt to Equity Ratio | 0.0125 |
| Current Ratio | 22.28 |
| Net Debt Paydown Yield | -0.01% |